Senseonics Holdings Inc

SENS

6.560USD

0.0000.00%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

Senseonics Holdings Inc's Score

Industry at a Glance

Industry Ranking

102 / 208

Overall Ranking

239 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Senseonics Holdings Inc Highlights

StrengthsRisks

Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 57.47% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 35.26M.

Fairly Valued

The company’s latest PE is -3.96, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 6.46M shares, decreasing 20.60% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.83M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.18.

Analyst Rating

Based on 8 analysts

Buy

Current Rating

18.917

Target Price

+214.23%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Senseonics Holdings Inc is 6.82, ranking 111 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 14.26M, representing a year-over-year increase of 71.82%, while its net profit experienced a year-over-year increase of 34.55%.

Score

Industry at a Glance

Previous score

6.82

Change

0



Financials

7.91

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.45

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.85

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.55

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.31

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Senseonics Holdings Inc is 7.07, ranking 128 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -3.96, which is -294.32% below the recent high of 7.70 and -2065.58% above the recent low of -85.77.

Score

Industry at a Glance

Previous score

7.07

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 102/208

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Senseonics Holdings Inc is 7.00, ranking 153 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 19.25, with a high of 31.00 and a low of 9.00.

Score

Industry at a Glance

Previous score

7.00

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Senseonics Holdings Inc is 7.48, ranking 19 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 8.23 and the support level at 5.10, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.49

Change

-0.01

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Senseonics Holdings Inc is 3.00, ranking 135 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 15.82%, representing a quarter-over-quarter decrease of 14.42%. The largest institutional shareholder is The Vanguard, holding a total of 1.83M shares, representing 4.39% of shares outstanding, with 35.62% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Energy Capital, L.L.C.

2.48M

+16.67%

The Vanguard Group, Inc.

Star Investors

1.71M

+2.24%

BlackRock Institutional Trust Company, N.A.

775.05K

-0.78%

Geode Capital Management, L.L.C.

448.98K

+3.20%

Hood River Capital Management LLC

427.71K

+7.96%

Goodnow (Timothy Todd)

333.26K

-2.87%

Masters Capital Management, L.L.C.

250.00K

+11.11%

Charles Schwab Investment Management, Inc.

219.86K

+2.08%

UBS Financial Services, Inc.

211.53K

+418.04%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Senseonics Holdings Inc is 3.38, ranking 127 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.05. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Senseonics Holdings Inc

SENS

6.30 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bioventus Inc

BVS

8.28 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.13 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.07 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Edwards Lifesciences Corp

EW

8.05 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment